Mylan obtained approval to market the generic dubbed Wixela Inhub in three strengths: fluticasone propionate 100 mcg/salmeterol 50 mcg, fluticasone propionate 250 mcg/salmeterol 50 mcg and ...

Mylan is now part of Viatris. Mylan did not admit to any wrongdoing, and neither did Pfizer, which settled related claims from the drug wholesalers for $50 million in 2023. A representative for ...